<DOC>
	<DOCNO>NCT01808378</DOCNO>
	<brief_summary>Evaluate use autologous ASC treatment bilateral limbic associate keratopathy</brief_summary>
	<brief_title>Stem Cells Treatment Bilateral Limbic Associated Keratopathy ( HULPOFT )</brief_title>
	<detailed_description>Intralesional use inject adipose derive stem cell</detailed_description>
	<criteria>1 . Signed informed consent 2 . Previously diagnose bilateral limbic obstruction 3 . Men woman 18 year old . Good general state health accord finding clinical history physical examination 4 . Suffering chronic keratopathy accomplish follow criterion : Confirmed limbic obstruction impression cytology Repeated usual treatment failure pathology 1 . Having suffer neoplasia previous 5 year 2 . Local anesthesia allergy 3 . Patients participate study previous 90 day inclusion 4 . Patients medication tacrolimus cyclosporine 4 previous week cellular therapy 5 . Any medical psychiatric illness , investigator opinion , could suppose reason study exclusion 6 . Patients type medical psychiatric disease , opinion investigator , could ground exclusion study 7 . Patients congenital acquire immunodeficiency . HIV , HBV , HCV treponema infection , whether active latent 8 . Patients suffer major surgery severe trauma prior 6 month 9 . Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Bilateral limbic associate keratopathy</keyword>
	<keyword>Expanded Adipose Derived Stem Cells</keyword>
</DOC>